TITLE:
Study of Enfuvirtide in HIV-Positive Subjects

CONDITION:
HIV Infections

INTERVENTION:
Fuzeon

SUMMARY:

      A total of 26 patients will be admitted to the clinic where they will be dosed with each
      injection device. There will be a 7-day washout between doses and a 7-10 day follow-up
      period.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to 64 Years
Criteria:

        Inclusion Criteria:

        Exclusion Criteria:
      
